ALLMedicine™ Aplastic Anemia Center
Research & Reviews 914 results
Hematology (Amsterdam, Netherlands); Zhang Y, Liu L et. al.
Sep 24th, 2021 - To compare the outcomes of antihuman T lymphocyte globulin (ATG-F) and porcine antihuman lymphocyte globulin (p-ALG) as part of a conditioning regimen in hematopoietic stem cell transplantation (HSCT) for severe aplastic anemia (SAA). we performed...
https://doi.org/10.1007/s00277-021-04664-z 10.1182/asheducation-2018.1.467 10.1182/asheducation-2016.1.90 10.1016/j.bbmt.2010.06.011 10.1016/j.bbmt.2008.07.003 10.1016/j.bbmt.2016.07.002 10.1038/bmt.2017.169 10.1182/blood-2014-09-599241 10.1182/blood-2010-08-295832 10.1016/j.bbmt.2018.09.039 10.1016/j.imlet.2014.01.013 10.1532/IJH97.06239 10.1016/j.bbmt.2008.12.497 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o 10.1111/j.2517-6161.1972.tb00899.x 10.1080/01621459.1999.10474140 10.1038/bmt.2012.244 10.1182/bloodadvances.2018025643 10.1182/blood-2018-01-829630 10.1182/blood-2006-03-005041 10.3324/haematol.2009.018267 10.1016/j.bbmt.2006.04.005 10.1016/j.bbmt.2017.03.036 10.1016/j.bbmt.2010.05.014 10.1038/sj.bmt.1705618 10.1016/j.bbmt.2014.01.020
Annals of Hematology; Hiramoto N, Yamazaki H et. al.
Sep 22nd, 2021 - Thus far, there have been no large cohort studies on total body irradiation (TBI)-containing conditioning regimens without antithymocyte globulin (ATG) in adults with aplastic anemia (AA) undergoing umbilical cord blood (UCB) transplantation (UCBT...
International Journal of Laboratory Hematology; Yu W, Yang W
Sep 17th, 2021 - Accumulating evidence has indicated that interleukin (IL)-27 and its gene polymorphisms exert pivotal impact on several autoimmune disorders. This research intended to investigate the relationship between IL-27 rs153109 polymorphism with risk and ...
Blood Patel BA, Groarke EM et. al.
Sep 16th, 2021 - Patients with severe aplastic anemia (SAA) are either treated with bone marrow transplant (BMT) or immunosuppression (IST) depending on their age, comorbidities, and available donors. In 2017, our phase 2 trial reported improved hematologic respon...
BMC Infectious Diseases; Brewer D, MacMillan ML et. al.
Sep 12th, 2021 - Cerebral toxoplasmosis infection presents with non-specific neurologic symptoms in immunocompromised patients. With lack of measurable adaptive immune responses and reluctance to sample affected brain tissue, expedient diagnosis to guide directed ...
Guidelines 1 results
Haematologica Bennett JM, Orazi A
Jan 16th, 2009 - Members of the French-American-British Cooperative Leukemia Working Group met to review cases of aplastic anemia, hypocellular myelodysplastic syndrome and hypocellular acute myeloid leukemia. Criteria were proposed and modified following three wo...
Drugs 131 results see all →
Clinicaltrials.gov 2 results
Oct 27th, 2017 - BACKGROUND: Aplastic anemia (AA) remains a life-threatening illness. Treatment options include supportive care (transfusions, growth factors, etc.), immunosuppression therapy and stem cell transplantation. Only the latter two have favorably impact...
Jun 29th, 2016 - The trial proposed is a single arm phase II multicenter treatment protocol designed to examine engraftment, toxicity, graft-versus-host disease, and ultimate disease-free survival following a novel cytoreductive regimen including busulfan, cycloph...
News 56 results
Mark S. Lesney
Mar 6th, 2020 - Inferior overall survival was observed in patients with aplastic anemia who had mixed or complete recipient-type chimerism or complete donor chimerism after hematopoietic stem cell transplantation (HSCT), according to the results of a registry dat.
Oct 7th, 2019 - Treatment of Acquired Aplastic Anemia Supportive Care While the workup and treatment plan are being established, attention should be directed at supportive care for prevention of complications. The most common complications leading to death in pat.
Dominick A, Fields-Meehan JE et. al.
Sep 5th, 2019 - Background: Dual immune checkpoint blockade (DICB) is utilized for a variety of malignancies. These therapies have a unique and often unpredictable side effect profile compared to conventional chemotherapy.
Jan 23rd, 2019 - Immunosuppressive Therapy For patients without an HLA-matched sibling donor or those who are older than 50 years of age, immunosuppressive therapy is the first-line therapy. ATG and cyclosporine A are the treatments of choice.
Jan 18th, 2019 - In addition to peripheral blood findings, bone marrow biopsy is essential for the diagnosis, and should demonstrate a markedly hypocellular marrow (cellularity < 25%), occasionally with an increase in T lymphocytes. 7,39 Because marrow cellularity.